Federal Trade Commission
600 Pennsylvania Avenue, N.W.
Washington
D.C.
20580
United States
Tel: 877-382-4357-Or-202-326-2222
Website: http://www.ftc.gov/
73 articles with Federal Trade Commission
-
The vote came just over one week after the FTC announced it would probe claims regarding the role the middlemen play in determining retail prices of prescription drugs.
-
Calls for a reform of drug prices have become a regular occurrence, particularly in the midst of political campaigns. Yet a new report shows the median price of a new drug launched in 2021 was $180,000.
-
AbbVie’s Allergan Aesthetics announced it was buying Soliton in a deal worth about $550 million. Now, the Federal Trade Commission has requested additional information about the deal.
-
Grail presents its first data from the interventional PATHFINDER trial of Galleri, its multi-cancer early detection blood test. Galleri is now available in the U.S. by prescription.
-
The goal is to “identify concrete and actionable steps to review and update the analysis of pharmaceutical mergers.”
-
The U.S. Federal Trade Commission gave the green light to the $63 billion merger of AbbVie and Allergan. That leaves one last hurdle for the two companies, approval from the Irish High Court.
-
FDA and FTC Issue Warning Letters to Seven Companies Selling Fraudulent COVID-19 ‘Treatments’
3/10/2020
The U.S. Food and Drug Administration is putting a halt to the sale of alleged treatments for COVID-19 due to concerns about the safety risks these products could have to the public. -
Vizient to Present at FDA/FTC Workshop on a Competitive Marketplace for Biosimilars
3/9/2020
Vizient, Inc. announces it will participate in Food and Drug Administration /Federal Trade Commission Workshop on a Competitive Marketplace for Biosimilars in Silver Spring, Maryland.
-
FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products to Help Americans
2/3/2020
The U.S. Food and Drug Administration and the Federal Trade Commission today signed a joint statement regarding enhanced collaboration in support of a robust marketplace for biological products, including the critical adoption of biosimilars and interchangeable products.
-
The FTC alleges that Illumina is trying to unlawfully maintain a monopoly in the U.S. market for next-generation DNA sequencing systems by removing PacBio as a competitive threat.
-
On Thursday, FTC staff reviewing Roche’s $4.8 billion bid for Spark gave the deal a thumbs up after reviewing the potential merger.
-
Specifically, the civil subpoenas were issued to determine if the company had violated antitrust laws with its rheumatoid arthritis drug Remicade.
-
“Bristol-Myers Squibb is committed to working with regulatory authorities around the world on the proposed combination with Celgene,” the company stated. “The company is focused on realizing the promise of the transaction, and is continuing to work to complete the transaction on a timely basis.”
-
Teva Finalizes Settlement with Federal Trade Commission to Resolve All Outstanding Litigation between the Parties
2/19/2019
Teva Pharmaceutical Industries Ltd. announced a settlement with the Federal Trade Commission that will resolve all outstanding litigation between the parties.
-
FDA, FTC take action against companies misleading kids with e-liquids that resemble children's juice boxes, candies and cookies
5/1/2018
The U.S. Food and Drug Administration and the Federal Trade Commission (FTC) issued 13 warning letters to manufacturers, distributors, and retailers for selling e-liquids used in e-cigarettes with labeling and/or advertising that cause them to resemble kid-friendly food products.
-
Concert Pharma Receives Second Request From FTC Under HSR Act
5/22/2017
-
Shire Responds To U.S. FTC Civil Action
2/9/2017
-
FTC Sues Shire ViroPharma for Using Illegal Tactics to Block Generic Competition
2/8/2017
-
Endo International Release: Pharma Announces Agreement To Resolve FTC Investigation And Litigation
1/24/2017
-
Martin Shkreli's Complaint Leads to a $100 Million FTC Settlement for This Biotech
1/20/2017